The genetic factors predisposing to essential tremor (ET), of one of the most common movement 31 disorders, remains largely unknown. While current studies have examined the contribution of 32 both common and rare genetic variants, very few have investigated the ET transcriptome. To 33 understand pathways and genes relevant to ET, we used an RNA sequencing approach to 34 interrogate the transcriptome of two cerebellar regions, the dentate nucleus and cerebellar cortex, 35 in 16 cases and 16 age-and sex-matched controls. Additionally, a phenome-wide association 36 study (pheWAS) of the dysregulated genes was conducted, and a genome-wide gene association 37 study (GWGAS) was done to identify pathways overlapping with the transcriptomic data. We 38 identified several novel dysregulated genes including CACNA1A, a calcium voltage-gated 39 channel implicated in ataxia. Furthermore, several pathways including axon guidance, olfactory 40 loss, and calcium channel activity were significantly enriched. A subsequent examination of the 41 ET GWGAS data (N=7,154) also flagged genes involved in calcium ion-regulated exocytosis of 42 neurotransmitters to be significantly enriched. Interestingly, the pheWAS identified that the 43 dysregulated gene, SHF, is associated with a blood pressure medication (P=9.3E-08), which is 44 commonly used to reduce tremor in ET patients. Lastly, it is also notable that the dentate nucleus 45 and cerebellar cortex have different transcriptomes, suggesting that different regions of the 46 cerebellum have spatially different transcriptomes. 47
Six genes were differentially expressed in the cerebellar cortex and two genes were differentially 85 expressed for the dentate nucleus for an FDR of 0.05 (Table 1 ). The QQ-plot did not show any 86 large stratification of the data in cerebellar cortex or dentate nucleus (Supplementary Figure 1,  87 2). Interestingly, the top dentate nucleus differentially expressed genes differed compared to the 88 cerebellar cortex. The top non-coding RNA differentially expressed was LINC00599 in the 89 cerebellar cortex, which was highly associated with calcium ion-regulated exocytosis of 90 neurotransmitter (P = 3.3E-06), ionotropic glutamate receptor signaling pathway (P = 9.2E-10), 91 neurotransmitter secretion (P = 1.6E-09) and synaptic vesicle exocytosis (P=1.0E-07) in the GO 92 database based on GeneNetwork's co-expression database. Pathway analyses of the DEGs based 93 on co-expression identified six clusters for the differentially expressed genes (Figure 1 ). Several 94 novel pathways possibly implicated in ET were identified including axon guidance, olfactory 95 receptor activity, and voltage-gated calcium channel activity for the cerebellar cortex (Table 2) . 96
Two gene clusters were identified for the dentate nucleus (Figure 2 ). Many pathways were 97 enriched in the dentate nucleus, including olfactory transduction, olfactory signaling pathway 98 and MAPK signaling ( To narrow down relevant pathways, a genome-wide gene association study (GWGAS) was done. 113
The input SNPs were mapped to 18,220 protein coding genes. The genome-wide gene 114 association study (GWGAS) identified BUB1 reaching Bonferroni genome-wide significance 115 and several genes reaching suggestive significance ( Figure 3A) . Clustering of the genes based on 116 co-expression identified four distinct clusters (Supplementary Figure 5) . From the pathway 117 analyses, calcium ion-regulated exocytosis of neurotransmitters in GO was significantly enriched 118 in the pathway in cluster three (P=9.7E-03). Gene-level enrichment analyses in GTEx 30 v7 119 found the brain to be significantly associated (P=0.001). After, the enrichment was queried in the 120 brain-relevant regions of GTEx 53 v7 we found the cerebellar cortex and frontal cortex to pass 121
Bonferroni-corrected significance ( Figure 3B The phenome-wide association study (pheWAS) showed that SHF was significantly associated 126 with blood pressure medication (P=9.30E-08) and body mass index (BMI) (P=1.5E-07) (Figure  127 4 Additionally, the gene has been shown to be highly co-expressed with GABRA4 based on the 142
Gene Network database (P=1.6E-13), reinforcing CACNA1A as a gene of interest for ET. 143
144
The top DEG, PRKG1, has been shown to regulate cardiovascular and neuronal health 9 . 145
Specifically, the RNA isoform two (PRKG1B) was most significantly differentially expressed at 146 the transcript level. Currently, there has yet to be any study to link PRKG1 and ET. However, the 147 gene is highly expressed in Purkinje cells, which is a relevant cerebellar cell type in ET 12 . Also, 148 the ET brain staining did not show significant Purkinje cell loss, suggesting transcriptomic 149 dysregulation of Purkinje cells may be more relevant to ET than degeneration. Interestingly, 150
PRKG1 has been associated with alcohol misuse and many ET patients report reduced tremor 151 intensity with alcohol, however, the pheWAS data did not show any associations 13 . 152 The FASTQ files were pseudo-aligned using Salmon using the Ensembl v94 annotation of the 224 human genome 19 . For data processing and parameters of Salmon, please refer to Liao et al. 225 (2019) 15 . Sleuth was used to identify DEGs 20 . The data was analyzed with the following full 226 model for the likelihood ratio test: Gene expression ~ disease status + sex + age + sex:disease 227 status + age:sex + sex:disease status. The reduced model for the likelihood ratio test is: Gene 228 expression ~ sex + age + sex:age. A Wald test was used to get beta values, which is a bias 229 estimator. Beta approximates the extent at which estimated counts is affected by the disease 230 status rather than technical and biological variability. It can be used to estimate the magnitude 231 and direction of fold change. P-values were corrected using the Benjamini-Hochberg procedure 232 to account for false discovery rate (FDR). Q-value (p-values corrected for FDR) significance was 233 set for <0.05. Splicing analyses were done with SUPPA2 and rMATs 21, 22 . 234 . 246
Tissue specificity was tested in GTEx 53 v7. Briefly, DEG sets were pre-made and the input 247 genes were tested against the DEG sets using a hypergeometric test. DEGs with a q-value <0.30 248 were included for analysis. 249 250
Gene-level analyses of ET GWAS data 251
The raw genotyping data from the discovery cohort of the 2016 ET GWAS was obtained 252 (N=7154). Data quality control included the following: Hardy-Weinberg equilibrium t-test P < 253 1E-4, minor allele frequency MAF > 0.05, genotype missingness < 2%, and sex discordance. 254
Imputation was performed using EAGLE2 and PWBT, using the Sanger Imputation Service, and 255 samples with INFO < 0.3 were removed. The data was analyzed using BOLT-LMM with 15principle components Tables and Figures. 276 
